Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03328-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Yutaro Tasaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. pursue.and.realize@gmail.com. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Chemoradiotherapy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endoscopic submucosal dissection (ESD) is a potentially efficient therapeutic intervention for superficial esophageal cancer. Additional treatment such as chemoradiotherapy (CRT) or esophagectomy is recommended in cases of muscularis mucosa invasion with positive resection margins or lymphovascular invasion or submucosal layer invasion, which are considered noncurative ESD, due to an increased risk of lymph node metastasis. However, the adequacy of additional CRT after near-circumferential or full-circumferential noncurative ESD has not been fully discussed. In this study, we retrospectively evaluated the efficacy and toxicity of additional CRT for superficial esophageal squamous cell carcinoma (SCC) after near-circumferential or full-circumferential noncurative ESD, which was defined as a mucosal defect measuring ≥ 3/4 of the esophageal circumference.
Methods
We retrospectively evaluated 24 patients who received additional CRT for superficial esophageal SCC after near-circumferential or full-circumferential noncurative ESD between 2012 and 2018. Elective nodal irradiation (ENI) was performed in all patients and boost irradiation (BI) was performed after ENI in 4 patients with positive resection margins. The prescription doses of ENI and BI were 41.4 Gy in 23 fractions and 9 Gy in 5 fractions, respectively. Concurrent chemotherapy (a combination of cisplatin or nedaplatin and 5-fluorouracil) was administered to all patients.
Results
The 3-year and 5-year overall survival rates were 92% and 78%, respectively, while the 3-year and 5-year progression-free survival rates were 83% and 70%, respectively. Grade 2 esophageal stenosis occurred in 8 (33%) patients. There was no case of Grade 3 or worse esophageal stenosis. Among them, 4 (17%) patients developed stenosis before additional CRT, which persisted after the completion of additional CRT. The remaining 4 (17%) patients developed de novo stenosis within 5 months following the completion of additional CRT. One patient (4%) still requires regular bougie dilation. Grade 3 and Grade 4 acute toxicity, including anemia, neutropenia, thrombocytopenia, and esophagitis occurred in 1 (4%) and 0 (0%), 6 (25%) and 1 (4%), 1 (4%) and 0 (0%), and 1 (4%) and 0 (0%) patients, respectively. One (4%) patient who underwent salvage CRT for the out-of-field lymph node recurrence died with acute myeloid leukemia.
Conclusions
Additional CRT is a viable treatment option even in patients who have undergone near-circumferential or full-circumferential noncurative ESD. Esophageal stenosis after additional CRT following near-circumferential or full-circumferential noncurative ESD is manageable and acceptable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. pursue.and.realize@gmail.com.
- Department of Radiology, Sasebo Central Hospital, 15 Daiwa, Sasebo, 857-1195, Japan.
- Department of Radiology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
- Department of Radiology, National Hospital Organization Nagasaki Medical Center, 1000-1 Kubara, Omura, 856- 8562, Japan.
- Department of Radiology, Japanese Red Cross Nagasaki Genbaku Hospital, 3-15 Mori, Nagasaki, 852-8511, Japan.
- Department of Clinical Oncology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Zitieren
APA
Tasaki, Y., Yamazaki, T., Miyazaki, S., Takeda, T., Nakatake, M., Nakamura, D., Takahira, A., Honda, K., Egawa, A., Yamaguchi, N., Nakao, K., & Toya, R. (2024). Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03328-2
Vancouver
Tasaki Y, Yamazaki T, Miyazaki S, Takeda T, Nakatake M, Nakamura D, et al. Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03328-2
BibTeX
@article{Tasaki2024,
author = {Tasaki, Yutaro and Yamazaki, Takuya and Miyazaki, Shuhei and Takeda, Tatsuya and Nakatake, Mika and Nakamura, Daisuke and Takahira, Asuka and Honda, Koichi and Egawa, Akiko and Yamaguchi, Naoyuki and Nakao, Kazuhiko and Toya, Ryo},
title = {Additional chemoradiotherapy for superficial esophageal squamous cell carcinoma after near-circumferential or full-circumferential noncurative endoscopic submucosal dissection: a retrospective study},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03328-2}
}
EUVIMED